Elanix Biotechnologies AG (FRA: ELN), a developer of tissue regeneration products and specialty cosmetics in dermatology and gynaecology, announced today the launch of its topical womens’ health product, GYNrepair® Cream in the European Union. GYNrepair® Cream contains a proprietary Cell Free Protein Complex (CFPC®), including various proteins, such as collagen and fibronectin, and is perfume-free. It is specifically designed for use on the genital external mucosa to soothe the feeling of discomfort and dryness. GYNrepair® Cream can be ordered at www.repair-a.com. Approximately 10-15% of all women seeking gynaecological help suffer from intimate discomfort, twinges and dryness that result from several conditions, including vestibulodynia, vulvodynia, pudendal nerve entrapment and persistent genital arousal disorder. Recommended treatment varies considerably from medications and creams to physical therapy, stress management and holistic approaches.
Elanix’s commercialization strategy to expand the availability of GYNrepair® Cream in the next 12 months, includes:
Consumer e-commerce platform – hosted by its Swiss subsidiary, REPAIR-A, the newly available web portal will provide customers an easy to use, secure and discreet ordering experience.
Distributors and wholesalers – negotiations continue to market its CFPC®-Creams more broadly in the EU and existing market, Switzerland.
Direct sales – the cost-effectiveness of contracting direct sales personnel in select countries/regions is being evaluated.
“The launch of GYNrepair® Cream in the EU and expansion of its availability in Switzerland via our dedicated website is a major milestone for Elanix, and the first in our commercialization expansion strategy for the product,” stated Tomas Svoboda, CEO of Elanix Biotechnologies. “The feedback from women using GYNrepair® Cream is overwhelmingly positive. Our new website provides women with an easily accessible platform to have GYNrepair® Cream delivered to their homes. We are also developing a smartphone app to help with application adherence and one-click re-ordering option.”